Tumor necrosis factor/cachectin (TNF/C) is the principal mediator of bacterial endotoxin-induced shock and death. We found that the C3H/HeJ mouse, which is less able to produce TNF/C in response to endotoxin, has a 1,000-fold greater susceptibility to lethal infection with Escherichia coli than the TNF-responsive congenic mouse, C3H/HeN. This surprising finding suggested that this lethal peptide may also be involved in host protection. To test this hypothesis we pretreated the C3H/HeJ mouse with a combination of recombinant murine TNF/C-alpha and IL-1 alpha. This combination protected these mice against an intraperitoneal bacterial challenge of greater than 20 LD50S (nearly 2 x 10(2) CFU) that grew to a level of greater than 10(7) CFU/ml of blood and per gram of liver in untreated mice. This suggests a significant role for these cytokines in host defenses against invasive infections that require bacterial replication within the host. These protective mechanisms may not be important for less virulent organisms. These findings may have important implications for the proposed use of anti-TNF/C agents in the treatment of septic shock.
Skip Nav Destination
Article navigation
1 June 1989
Article|
June 01 1989
Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection.
A S Cross,
A S Cross
Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, DC 20307.
Search for other works by this author on:
J C Sadoff,
J C Sadoff
Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, DC 20307.
Search for other works by this author on:
N Kelly,
N Kelly
Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, DC 20307.
Search for other works by this author on:
E Bernton,
E Bernton
Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, DC 20307.
Search for other works by this author on:
P Gemski
P Gemski
Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, DC 20307.
Search for other works by this author on:
A S Cross
,
J C Sadoff
,
N Kelly
,
E Bernton
,
P Gemski
Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, DC 20307.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1989) 169 (6): 2021–2027.
Citation
A S Cross, J C Sadoff, N Kelly, E Bernton, P Gemski; Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection.. J Exp Med 1 June 1989; 169 (6): 2021–2027. doi: https://doi.org/10.1084/jem.169.6.2021
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement